Bridget Knight

16.1k total citations · 1 hit paper
80 papers, 3.1k citations indexed

About

Bridget Knight is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Bridget Knight has authored 80 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Surgery and 22 papers in Genetics. Recurrent topics in Bridget Knight's work include Pancreatic function and diabetes (23 papers), Diabetes Management and Research (19 papers) and Diabetes and associated disorders (17 papers). Bridget Knight is often cited by papers focused on Pancreatic function and diabetes (23 papers), Diabetes Management and Research (19 papers) and Diabetes and associated disorders (17 papers). Bridget Knight collaborates with scholars based in United Kingdom, United States and Norway. Bridget Knight's co-authors include Andrew T. Hattersley, Beverley M. Shields, Timothy J. McDonald, Angus G. Jones, Anita Hill, Rachel Besser, Michael N. Weedon, Timothy M. Frayling, Roy Powell and Maggie Shepherd and has published in prestigious journals such as Bioinformatics, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Bridget Knight

79 papers receiving 3.0k citations

Hit Papers

Large-Scale Association Studies of Variants in Genes Enco... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bridget Knight United Kingdom 30 1.4k 1.3k 1.3k 825 423 80 3.1k
Diva D. De León United States 35 1.9k 1.4× 888 0.7× 2.4k 1.9× 925 1.1× 464 1.1× 121 3.9k
Diane Brisson Canada 34 1.2k 0.9× 787 0.6× 1.0k 0.8× 1.6k 2.0× 849 2.0× 115 4.3k
Sayuko Kobes United States 31 544 0.4× 1.3k 0.9× 620 0.5× 1.2k 1.4× 315 0.7× 86 3.3k
Tohru Yorifuji Japan 35 982 0.7× 1.1k 0.8× 960 0.7× 1.5k 1.8× 481 1.1× 168 3.6k
Petr Volkov Sweden 22 795 0.6× 795 0.6× 382 0.3× 1.9k 2.4× 545 1.3× 30 2.8k
Henrik U. Andersen Denmark 32 1.3k 0.9× 944 0.7× 1.4k 1.1× 588 0.7× 79 0.2× 116 3.0k
Nobuo Matsuura Japan 30 682 0.5× 1.3k 0.9× 1.3k 1.0× 854 1.0× 283 0.7× 127 3.2k
Gina M. Peloso United States 24 496 0.4× 713 0.5× 320 0.2× 552 0.7× 171 0.4× 77 2.1k
Mirjam Faulenbach United States 15 903 0.7× 755 0.6× 952 0.7× 950 1.2× 95 0.2× 21 3.1k
Alanna C. Morrison United States 32 357 0.3× 1.0k 0.8× 363 0.3× 1.1k 1.3× 273 0.6× 119 2.8k

Countries citing papers authored by Bridget Knight

Since Specialization
Citations

This map shows the geographic impact of Bridget Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget Knight more than expected).

Fields of papers citing papers by Bridget Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bridget Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget Knight. The network helps show where Bridget Knight may publish in the future.

Co-authorship network of co-authors of Bridget Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Bridget Knight. A scholar is included among the top collaborators of Bridget Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bridget Knight. Bridget Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Thompson, William, Robin N. Beaumont, Alan Kuang, et al.. (2021). Fetal alleles predisposing to metabolically favorable adiposity are associated with higher birth weight. Human Molecular Genetics. 31(11). 1762–1775. 3 indexed citations
3.
Thompson, William, Robin N. Beaumont, Alan Kuang, et al.. (2021). Higher maternal adiposity reduces offspring birthweight if associated with a metabolically favourable profile. Diabetologia. 64(12). 2790–2802. 7 indexed citations
4.
Knight, Bridget, Francis B. Stephens, Benjamin T. Wall, et al.. (2021). Extreme longevity variants at the FOXO3 locus may moderate FOXO3 isoform levels. GeroScience. 44(2). 1129–1140. 5 indexed citations
5.
Jeffery, Nicola, Benjamin P. Lee, Bridget Knight, et al.. (2021). Persistence of clinically relevant levels of SARS-CoV2 envelope gene subgenomic RNAs in non-immunocompromised individuals. International Journal of Infectious Diseases. 116. 418–425. 11 indexed citations
6.
Beaumont, Robin N., Sarah J. Kotecha, Andrew R. Wood, et al.. (2020). Common maternal and fetal genetic variants show expected polygenic effects on risk of small- or large-for-gestational-age (SGA or LGA), except in the smallest 3% of babies. PLoS Genetics. 16(12). e1009191–e1009191. 13 indexed citations
7.
Thompson, William, Jessica Tyrrell, Maria Carolina Borges, et al.. (2019). Association of maternal circulating 25(OH)D and calcium with birth weight: A mendelian randomisation analysis. PLoS Medicine. 16(6). e1002828–e1002828. 32 indexed citations
8.
Bowman, Pamela, Timothy J. McDonald, Bridget Knight, et al.. (2019). Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-KATP-channel pathways. BMJ Open Diabetes Research & Care. 7(1). e000721–e000721. 8 indexed citations
9.
Hammersley, S., Timothy J. McDonald, Beverley M. Shields, et al.. (2019). Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?. Diabetic Medicine. 36(9). 1092–1099. 27 indexed citations
10.
Hughes, Alice E., Michael Nodzenski, Robin N. Beaumont, et al.. (2018). Fetal Genotype and Maternal Glucose Have Independent and Additive Effects on Birth Weight. Diabetes. 67(5). 1024–1029. 33 indexed citations
11.
Bowman, Pamela, Jacob Day, Lorna Torrens, et al.. (2018). Cognitive, Neurological, and Behavioral Features in Adults With KCNJ11 Neonatal Diabetes. Diabetes Care. 42(2). 215–224. 21 indexed citations
12.
Dennis, John, Beverley M. Shields, Anita Hill, et al.. (2018). Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy. Diabetes Care. 41(4). 705–712. 59 indexed citations
13.
Knight, Bridget, Beverley M. Shields, Xuemei He, et al.. (2018). Effect of perchlorate and thiocyanate exposure on thyroid function of pregnant women from South-West England: a cohort study. Thyroid Research. 11(1). 9–9. 39 indexed citations
14.
Shields, Beverley M., Maggie Shepherd, Michelle Hudson, et al.. (2017). Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients. Diabetes Care. 40(8). 1017–1025. 97 indexed citations
15.
Joshi, Shivam, et al.. (2016). Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling. Nutrition and Diabetes. 6(12). e235–e235. 23 indexed citations
16.
Munkley, Jennifer, Daniel Vodák, Karen E. Livermore, et al.. (2016). Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability. EBioMedicine. 8. 103–116. 75 indexed citations
17.
Oram, Richard A., Andrew Rawlingson, Beverley M. Shields, et al.. (2013). Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study. BMJ Open. 3(12). e003193–e003193. 18 indexed citations
18.
Shields, Beverley M., Jaime Peters, Chris Cooper, et al.. (2012). Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol. BMJ Open. 2(6). e002309–e002309. 4 indexed citations
19.
Bowman, Pamela, Timothy J. McDonald, Beverley M. Shields, Bridget Knight, & Andrew T. Hattersley. (2011). Validation of a single‐sample urinary C‐peptide creatinine ratio as a reproducible alternative to serum C‐peptide in patients with Type 2 diabetes. Diabetic Medicine. 29(1). 90–93. 26 indexed citations
20.
Shields, Beverley M., Rachel M. Freathy, Bridget Knight, et al.. (2009). Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy. The Journal of Clinical Endocrinology & Metabolism. 94(11). 4608–4612. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026